Adalimumab Reduces Photoreceptor Cell Death in A Mouse Model of Retinal Degeneration.
Ontology highlight
ABSTRACT: Growing evidence suggests that inflammation is involved in the progression of retinitis pigmentosa (RP) both in patients and in animal models. The aim of this study was to investigate the effect of Adalimumab, a monoclonal anti-TNFα antibody, on retinal degeneration in a murine model of human autosomal recessive RP, the rd10 mice at postnatal day (P) 18. In our housing conditions, rd10 retinas were seriously damaged at P18. Adalimumab reduced photoreceptor cell death, as determined by scoring the number of TUNEL-positive cells. In addition, nuclear poly (ADP) ribose (PAR) content, an indirect measure of PAR polymerase (PARP) activity, was also reduced after treatment. The blockade of TNFα ameliorated reactive gliosis, as visualized by decreased GFAP and IBA1 immunolabelling (Müller cell an
SUBMITTER: Martinez-Fernandez de la Camara C
PROVIDER: S-EPMC4501000 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA